| Document Date: 2013-07-25 14:47:25
Open Document File Size: 172,79 KBShare Result on Facebook
Company Cary LC / Ameba Laboratory / / Country United States / / / Event FDA Phase / / IndustryTerm resonance imaging / diagnostic services / imaging / / MedicalCondition Waterborne and Environmental Diseases / Gotuzzo E. Balamuthia mandrillaris infection / Zoonotic Infectious Diseases E-mail / disease / Balamuthia mandrillaris amoebic infection / Balamuthia mandrillaris meningoencephalitis / Not Receive Miltefosine Balamuthia infections Other infections / granulomatous amoebic encephalitis / often fatal infections / leishmaniasis / Balamuthia infections / disseminated Acanthamoeba sp infection / amebic encephalitis / acute lymphoblastic leukemia / Acanthamoeba keratitis / Granulomatous amebic encephalitis / Acanthamoeba spp. infections / Clinical Infectious Diseases / Infectious Diseases / B. mandrillaris infection / infections / FLA infections / / Organization CDC Emergency Operations Center / Division of Foodborne / National Center for Emerging / FDA / Centers for Disease Control and Prevention / / Person Sharon L. Roy / Jennifer R. Cope / Jonathan S. Yoder / Govinda Visvesvara / Jennifer Cope / / / Position using Fisher / Chief / / Product Investigational drug / / ProvinceOrState Mississippi / Florida / / PublishedMedium Current Opinion / Clinical Infectious Diseases / Journal of Clinical Microbiology / / Technology Magnetic resonance imaging / transplantation / MRI / / URL http /
SocialTag |
Increased Patient Survival: Miltefosine for Treatment of Free-living Ameba Infections Caused by Acanthamoeba and Balamuthia Jennifer R. Cope, Sharon L. Roy, Jonathan S. Yoder, Michael J. Beach